A Randomized Double-Blinded Placebo-Controlled Trial to Investigate the

Recruiting

99 years or below

All

Phase 3

Brief description of study

4.0

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Medical Research
Age: 99 years or below
Gender: All

Updated on 25 May 2021. Study ID: 844793

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.

A Randomized Double-Blinded Placebo-Controlled Trial to Investigate the Efficacy Safety and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus) ARGX-113-1904

Brief description of study

Eligibility of study

Find a site